ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag disease medicine policy culture clinical trials evolution

Infusion of Artificial Intelligence in Biology
Meenakshi Prabhune, PhD | Feb 23, 2024 | 10 min read
With deep learning methods revolutionizing life sciences, researchers bet on de novo proteins and cell mapping models to deliver customized precision medicines.
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019 | 10+ min read
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Alternative Medicines
The Scientist | Jul 1, 2012 | 10+ min read
As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.
Bottom Line, Culture Clash Impeding Cooperation Of Managed-Care Organizations In Clinical Trials
Myrna Watanabe | Jun 23, 1996 | 10+ min read
Managed-Care Organizations In Clinical Trials RAY OF HOPE: Cancer-prevention specialist Jon Kerner says MCOs support Phase III trials in some cases. With the advent of managed-care organizations (MCOs) and their focus on cost competitiveness, academic scientists are concerned that clinical trials will suffer from decreased patient participation. MCOs, they say, have been refusing to pay for ancillary tests and procedures performed in the course of a trial that they would otherwise pay. Resear
Can Destroying Senescent Cells Treat Age-Related Disease?
Katarina Zimmer | Mar 1, 2020 | 10+ min read
A handful of clinical trials are underway to find out whether drugs that target senescent cells can slow the ravages of old age.
Updated July 9
Track COVID-19 Vaccines Advancing Through Clinical Trials
The Scientist | Apr 7, 2020 | 10+ min read
Find the latest updates in this one-stop resource, including efficacy data and side effects of approved shots, as well as progress on new candidates entering human studies.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Clinical Trials Debate Continues: Asian American women want their fair share of clinical trials--but what is fair?
Myrna Watanabe | Nov 8, 1998 | 6 min read
IMPROVEMENT ON THE WAY: NAWHO President Mary Chung says that better education within the Asian American community will incease participation of Asian American women in clinical trials. Asian Americans comprise approximately 4 percent of the U.S. population, and they now account for 4 percent of the women enrolled in U.S. National Institutes of Health-sponsored clinical trials. This satisfies the spirit of the NIH Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Resea
When Should Service Dogs Be Admitted into the Lab?
Jef Akst | Nov 1, 2018 | 10+ min read
Becoming a neuroscientist with a service dog by your side presents numerous challenges. Joey Ramp, who went back to college to study her own post-traumatic stress disorder, is learning this the hard way.
3D multicolored conceptual image representing hallucinogens and the human brain.
Natural High: Endogenous Psychedelics in the Gut and Brain
Iris Kulbatski, PhD | Sep 8, 2023 | 8 min read
Psychedelics are evolutionarily ancient compounds produced by fungi, plants, and microbes. Humans also synthesize psychedelics. Researchers want to know how and why.

Run a Search

ADVERTISEMENT